Back to today’s briefing

Story perspectives

HIV Medications May Cut Alzheimer's Risk by 13%

5/14/2025

40 3

Summary

UVA Researchers Discover Alzheimer's Prevention

A groundbreaking study from the University of Virginia reveals that HIV medications, particularly nucleoside reverse transcriptase inhibitors (NRTIs), could lower the risk of Alzheimer's disease by 6-13% each year. Analyzing data from over 270,000 patients, researchers are calling for clinical trials on inflammasome inhibitors, opening new doors for Alzheimer's prevention that could impact millions worldwide.

Summary

Australian Researchers Innovate

Australian researchers at the Walter and Eliza Hall Institute have made a groundbreaking discovery with WEHI-3773, a small molecule that inhibits the BAX protein, safeguarding neurons from death. This pivotal finding could pave the way for innovative treatments for neurodegenerative diseases such as Parkinson's and Alzheimer's, igniting hope for effective therapies that alter disease progression.

1 of 2

UVA Researchers Discover Alzheimer's Prevention

A groundbreaking study from the University of Virginia reveals that HIV medications, particularly nucleoside reverse transcriptase inhibitors (NRTIs), could lower the risk of Alzheimer's disease by 6-13% each year. Analyzing data from over 270,000 patients, researchers are calling for clinical trials on inflammasome inhibitors, opening new doors for Alzheimer's prevention that could impact millions worldwide.

1 / 2